Bolovan, L.M.; Panait, M.E.; Busca, A.; Stanciu, A.E.; Chiriac, D.; Mihalcea, C.E.; Hotnog, C.M.; Georgescu, M.T.; Voinea, S.C.; Prunoiu, V.M.;
et al. Variation in Immune and Inflammatory Blood Markers in Advanced Melanoma Patients Treated with PD-1 Inhibitors: A Preliminary Exploratory Study. Biomedicines 2025, 13, 1378.
https://doi.org/10.3390/biomedicines13061378
AMA Style
Bolovan LM, Panait ME, Busca A, Stanciu AE, Chiriac D, Mihalcea CE, Hotnog CM, Georgescu MT, Voinea SC, Prunoiu VM,
et al. Variation in Immune and Inflammatory Blood Markers in Advanced Melanoma Patients Treated with PD-1 Inhibitors: A Preliminary Exploratory Study. Biomedicines. 2025; 13(6):1378.
https://doi.org/10.3390/biomedicines13061378
Chicago/Turabian Style
Bolovan, Lucica Madalina, Marieta Elena Panait, Antonela Busca, Adina Elena Stanciu, Daniela Chiriac, Corina Elena Mihalcea, Camelia Mia Hotnog, Mihai Teodor Georgescu, Silviu Cristian Voinea, Virgiliu Mihail Prunoiu,
and et al. 2025. "Variation in Immune and Inflammatory Blood Markers in Advanced Melanoma Patients Treated with PD-1 Inhibitors: A Preliminary Exploratory Study" Biomedicines 13, no. 6: 1378.
https://doi.org/10.3390/biomedicines13061378
APA Style
Bolovan, L. M., Panait, M. E., Busca, A., Stanciu, A. E., Chiriac, D., Mihalcea, C. E., Hotnog, C. M., Georgescu, M. T., Voinea, S. C., Prunoiu, V. M., Brasoveanu, L. I., & Gales, L. N.
(2025). Variation in Immune and Inflammatory Blood Markers in Advanced Melanoma Patients Treated with PD-1 Inhibitors: A Preliminary Exploratory Study. Biomedicines, 13(6), 1378.
https://doi.org/10.3390/biomedicines13061378
